葡萄糖类1 (GLP-1) 对下丘脑养回路的作用
Eunsang Hwang1, Bryan Portillo1, Kevin W Williams1
1Center for Hypothalamic Research, Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.
Endocrinology
|September 5, 2025
概括
在下丘脑中的葡萄糖类-1 (GLP-1) 信号调节食欲和新陈代谢. 本综述探讨了GLP-1通路如何为治疗肥胖提供治疗潜力.
科学领域:
- 神经内分泌学
- 代谢调节
- 肥胖研究
背景情况:
- 像ARC,PVH和DMH这样的下丘脑核集成GLP-1信号.
- GLP-1 调节饮食行为,体重和葡萄糖平衡.
- 内生GLP-1和药物GLP-1都涉及不同的下丘脑电路.
研究的目的:
- 审查目前对下丘脑电路中的GLP-1信号的理解.
- 提出未来研究GLP-1核心途径的框架.
- 突出针对这些途径的肥胖治疗潜力.
主要方法:
- 对GLP-1研究近期进展的文献综述.
- 在GLP-1作用中涉及的不同和重叠的下丘脑电路的分析.
- 基于现有证据的概念框架的开发.
主要成果:
- 内生GLP-1 (来自NTS PPG神经元) 和GLP-1RA对特定的下丘脑核起作用.
- 机制包括电路冗余,多样化的信号集成和上下文依赖的连接体作用.
- 在下丘脑养回路中,GLP-1R配体表现出多种效应.
结论:
- 中央GLP-1通路复杂,涉及多个下丘脑核和整合模式.
- 了解这些循环对于开发有效的肥胖疗法至关重要.
- 针对中央GLP-1通道对代谢障碍具有显著的治疗前景.
相关概念视频
Regulation of Food Intake
339
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
339
Glucagon-like Receptor Agonists
415
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
415
GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
cAMP-dependent Protein Kinase Pathways
6.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
Hormonal Regulation
44.2K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
44.2K
Hormones Regulating Blood Glucose
4.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.0K


